Literature DB >> 33505759

Metastatic Adenocarcinoma of the Lung Presenting as a Soft Tissue Mass.

B Yglesias1, M Brooker2, R DeVito3, A Swiger1.   

Abstract

Lung cancer is the leading cause of cancer death in the United States, with more than 230,000 new cases, and approximately 150,000 deaths estimated for 2018. Lung cancer most commonly metastasizes to the brain, liver, lungs, bone, and adrenal system; however, there have been several cases of spread to soft tissues, with an incidence rate of approximately 0.75-9%. The objective of this case report is to highlight an unusual presentation of metastatic adenocarcinoma of the lung. In this case report, patient presented with a 3 × 3 cm soft tissue mass on the back. The mass was slowly growing but had become more painful and wished to have it excised. Preoperatively, the mass was suspected to be a sebaceous cyst but intraoperatively had deep attachments and other suspicious findings. Pathology had a positive immunoprofile for metastatic adenocarcinoma favoring a lung primary. Given this presentation of metastases, the prognosis is poor with a survival time decreasing to around 5 months. Overall, this case reinforces the importance of sending all soft tissue masses for final pathology with accurate labeling and the importance of immunohistochemical testing in aiding the identification of the primary.
Copyright © 2021 B. Yglesias et al.

Entities:  

Year:  2021        PMID: 33505759      PMCID: PMC7806362          DOI: 10.1155/2021/8856503

Source DB:  PubMed          Journal:  Case Rep Surg


  13 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Metastatic sites and survival in lung cancer.

Authors:  M Riihimäki; A Hemminki; M Fallah; H Thomsen; K Sundquist; J Sundquist; K Hemminki
Journal:  Lung Cancer       Date:  2014-08-02       Impact factor: 5.705

Review 3.  Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature.

Authors:  T A Damron; J Heiner
Journal:  Ann Surg Oncol       Date:  2000-08       Impact factor: 5.344

4.  Metastatic non-small cell lung carcinoma with involvement of extremity musculature: case report and review of the literature.

Authors:  G Ramakrishna; G F Harms; C Erlichman
Journal:  Mayo Clin Proc       Date:  2000-12       Impact factor: 7.616

5.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 6.  Soft tissue metastases in lung cancer: a review of the literature.

Authors:  C Perisano; M S Spinelli; C Graci; L Scaramuzzo; E Marzetti; C Barone; C Fabbriciani; G Maccauro
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-12       Impact factor: 3.507

7.  Lung cancer presenting as a soft-tissue metastasis.

Authors:  Candice Baldeo; Robert Ali; Vandana Seeram; Jeff House
Journal:  Case Rep Oncol       Date:  2015-04-16

8.  Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET/CT.

Authors:  Nghi C Nguyen; Bassem T Chaar; Medhat M Osman
Journal:  BMC Med Imaging       Date:  2007-12-12       Impact factor: 1.930

9.  Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma.

Authors:  S Kummar; M Fogarasi; A Canova; A Mota; T Ciesielski
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

10.  An innocent appearing subcutaneous nodule diagnoses a small cell lung cancer in a never-smoker female.

Authors:  Nupur Sinha; Masooma Niazi; Gilda Diaz-Fuentes; Richard Duncalf
Journal:  Case Rep Oncol Med       Date:  2014-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.